Compare Agilent Technologies Inc (A) vs Amcor PLC (AMCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Amcor PLC — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Amcor PLC trades at $47 (market cap $21.78B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Amcor PLC pays the higher dividend (5.52%). Which is the better fit depends on your goals.
| A | AMCR | |
|---|---|---|
Market Cap | $42.00B | $21.78B |
Sector | Health | Basic Materials |
52-Week High | $157.20 | $50.58 |
52-Week Low | $110.24 | $36.69 |
Enterprise Value | $43.55B | $36.90B |
Dividend Yield | 0.69% | 5.52% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
AMCR trades at $47.86, up 1.7% today, near the consensus price target of $47.00. The stock shows bullish technical signals from moving averages, with RSI indicating mild overbought conditions. Recent quarters saw earnings beats, with Q2 2026 EPS expected at $1.19. Revenue grew to $15.01B in 2025, though net income margin declined to 3.06%. The company expanded its packaging facility in China and partnered with Kelpi for sustainable solutions, signaling growth initiatives.
Outlook is cautiously optimistic with analyst consensus at Buy (64%), but risks include margin pressure and high P/E of 38.44. Investment appeal hinges on earnings delivery and cost management amid competitive and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Amcor PLC
Amcor is a global plastics packaging behemoth, with global sales of USD 14.5 billion in fiscal 2022 following the acquisition of Bemis in 2019. Amcor's operations span over 40 countries globally and include significant emerging-market exposure equating to circa 20% of sales. Amcor's capabilities span flexible and rigid plastic packaging, which sell into defensive food, beverage, healthcare, household, and personal-care end markets.
Read more on AMCR →
